利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

13 条记录 (耗时 0.022 秒)

    Determination of sleep quality for neurological disorders
    3.
    发明授权
    Determination of sleep quality for neurological disorders 有权

    公开(公告)号：US10300283B2

    公开(公告)日：2019-05-28

    申请号：US14247923

    申请日：2014-04-08

    申请人： Medtronic, Inc.

    发明人： Keith A. Miesel ,  Kenneth T. Heruth ,  Jonathan C. Werder ,  Steve R. LaPorte ,  Nina M. Graves

    IPC分类号： A61N1/36 ,  A61B5/0205 ,  A61B5/11 ,  A61B5/00 ,  A61M5/142 ,  A61M5/172 ,  A61B3/113 ,  A61B5/0476 ,  A61B5/08 ,  A61B5/145 ,  A61N1/365 ,  A61N1/372

    摘要： A device determines values for one or more metrics that indicate the quality of a patient's sleep based on sensed physiological parameter values. Sleep efficiency, sleep latency, and time spent in deeper sleep states are example sleep quality metrics for which values may be determined. The sleep quality metric values may be used, for example, to evaluate the effectiveness of a therapy delivered to the patient by a medical device. In some embodiments, determined sleep quality metric values are automatically associated with the therapy parameter sets according to which the medical device delivered the therapy when the physiological parameter values were sensed, and used to evaluate the effectiveness of the various therapy parameter sets. The medical device may deliver the therapy to treat a non-respiratory neurological disorder, such as epilepsy, a movement disorder, or a psychological disorder. The therapy may be, for example, deep brain stimulation (DBS) therapy.

    Clustering of recorded patient neurological activity to determine length of a neurological event
    5.
    发明授权
    Clustering of recorded patient neurological activity to determine length of a neurological event 有权
    记录患者神经活动的聚类，以确定神经系统事件的长度

    公开(公告)号：US09072832B2

    公开(公告)日：2015-07-07

    申请号：US14262634

    申请日：2014-04-25

    申请人： Medtronic, Inc.

    发明人： Mark G. Frei ,  Ivan Osorio ,  Nina M. Graves ,  Scott F. Schaffner ,  Mark T. Rise ,  Jonathon E. Giftakis ,  David L. Carlson

    IPC分类号： A61N1/36 ,  A61M5/172 ,  A61B5/04 ,  A61B5/0476 ,  A61B5/00

    CPC分类号： A61M5/1723 ,  A61B5/04001 ,  A61B5/0476 ,  A61B5/4094 ,  A61B5/6843 ,  A61B5/721 ,  A61N1/36025 ,  A61N1/36064 ,  A61N1/36082 ,  A61N1/361

    摘要： Apparatus and method detect a detection cluster that is associated with a neurological event, such as a seizure, of a nervous system disorder and update therapy parameters that are associated with a treatment therapy. The occurrence of the detection cluster is detected when the maximal ratio exceeds an intensity threshold. If the maximal ratio drops below the intensity threshold for a time interval that is less than a time threshold and subsequently rises above the intensity threshold, the subsequent time duration is considered as being associated with the detection cluster rather than being associated with a different detection cluster. Consequently, treatment of the nervous system disorder during the corresponding time period is in accordance with one detection cluster. Treatment therapy may be provided by providing electrical stimulation, drug infusion or a combination. Therapy parameters may be updated for each mth successive group of applications of the treatment therapy or for each nth detection cluster.

    摘要翻译： 装置和方法检测与神经系统疾病的神经系统事件如癫痫发作相关联的检测簇，以及与治疗疗法相关联的更新治疗参数。 当最大比例超过强度阈值时，检测到簇的出现。 如果最小比率在低于时间阈值的时间间隔下降到低于强度阈值，并且随后升高到强度阈值以上，则后续持续时间被认为与检测集群相关联，而不是与不同的检测集群相关联 。 因此，在相应时间段期间治疗神经系统疾病是根据一个检测群。 可以通过提供电刺激，药物输注或组合来提供治疗治疗。 治疗参数可以针对治疗疗法或第n个检测簇的每个第m个连续的应用组进行更新。

    Determination of sleep quality for neurological disorders
    6.
    发明授权
    Determination of sleep quality for neurological disorders 有权

    公开(公告)号：US11096591B2

    公开(公告)日：2021-08-24

    申请号：US16365731

    申请日：2019-03-27

    申请人： Medtronic, Inc.

    发明人： Keith A. Miesel ,  Kenneth T. Heruth ,  Jonathan C. Werder ,  Steve R. LaPorte ,  Nina M. Graves

    IPC分类号： A61N1/36 ,  A61M5/172 ,  A61B5/00 ,  A61B5/11 ,  A61M5/142 ,  A61B5/0205 ,  A61B3/113 ,  A61B5/08 ,  A61B5/145 ,  A61N1/365 ,  A61N1/372 ,  A61B5/369

    摘要： A device determines values for one or more metrics that indicate the quality of a patient's sleep based on sensed physiological parameter values. Sleep efficiency, sleep latency, and time spent in deeper sleep states are example sleep quality metrics for which values may be determined. The sleep quality metric values may be used, for example, to evaluate the effectiveness of a therapy delivered to the patient by a medical device. In some embodiments, determined sleep quality metric values are automatically associated with the therapy parameter sets according to which the medical device delivered the therapy when the physiological parameter values were sensed, and used to evaluate the effectiveness of the various therapy parameter sets. The medical device may deliver the therapy to treat a non-respiratory neurological disorder, such as epilepsy, a movement disorder, or a psychological disorder. The therapy may be, for example, deep brain stimulation (DBS) therapy.

    THERAPY ADJUSTMENT
    7.
    发明申请
    THERAPY ADJUSTMENT 有权

    公开(公告)号：US20220032064A1

    公开(公告)日：2022-02-03

    申请号：US17499618

    申请日：2021-10-12

    申请人： Medtronic, Inc.

    发明人： Jonathon E. Giftakis ,  Peter J. Kovach ,  Warren W. Ball ,  Jonathan C. Werder ,  Nina M. Graves ,  David C. Ullestad ,  Sarah B. Alme

    IPC分类号： A61N1/36

    摘要： An indication that a patient event occurred may be used to evaluate the efficacy of at least one therapy program and/or adjust therapy delivery to the patient. In some examples, the patient event indication includes patient input that may be received via an event indication button of a programming device. In some examples, therapy delivery may be adjusted by adjusting at least one therapy parameter value, switching therapy programs or therapy program groups or restarting a therapy cycle of a medical device.

    Clustering of Recorded Patient Neurological Activity to Determine Length of a Neurological Event
    10.
    发明申请
    Clustering of Recorded Patient Neurological Activity to Determine Length of a Neurological Event 有权
    记录患者神经活动以确定神经事件长度的聚类

    公开(公告)号：US20140309614A1

    公开(公告)日：2014-10-16

    申请号：US14262634

    申请日：2014-04-25

    申请人： Medtronic, Inc.

    发明人： Mark G. Frei ,  Ivan Osorio ,  Nina M. Graves ,  Scott F. Schaffner ,  Mark T. Rise ,  Jonathon E. Giftakis ,  David L. Carlson

    IPC分类号： A61M5/172 ,  A61N1/36

    CPC分类号： A61M5/1723 ,  A61B5/04001 ,  A61B5/0476 ,  A61B5/4094 ,  A61B5/6843 ,  A61B5/721 ,  A61N1/36025 ,  A61N1/36064 ,  A61N1/36082 ,  A61N1/361

    摘要： Apparatus and method detect a detection cluster that is associated with a neurological event, such as a seizure, of a nervous system disorder and update therapy parameters that are associated with a treatment therapy. The occurrence of the detection cluster is detected when the maximal ratio exceeds an intensity threshold. If the maximal ratio drops below the intensity threshold for a time interval that is less than a time threshold and subsequently rises above the intensity threshold, the subsequent time duration is considered as being associated with the detection cluster rather than being associated with a different detection cluster. Consequently, treatment of the nervous system disorder during the corresponding time period is in accordance with one detection cluster. Treatment therapy may be provided by providing electrical stimulation, drug infusion or a combination. Therapy parameters may be updated for each mth successive group of applications of the treatment therapy or for each nth detection cluster.

    摘要翻译： 装置和方法检测与神经系统疾病的神经系统事件（例如癫痫发作），与治疗疗法相关联的更新治疗参数相关联的检测簇。 当最大比例超过强度阈值时，检测到簇的出现。 如果最小比率在低于时间阈值的时间间隔下降到低于强度阈值，并且随后升高到强度阈值以上，则后续持续时间被认为与检测集群相关联，而不是与不同的检测集群相关联 。 因此，在相应时间段期间治疗神经系统疾病是根据一个检测群。 可以通过提供电刺激，药物输注或组合来提供治疗治疗。 治疗参数可以针对治疗疗法或第n个检测簇的每个第m个连续的应用组进行更新。